1. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298(14):1685-1687. doi:10.1001/jama.298.14.1685
2. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374-381. doi:10.1038/nrendo.2009.106
3. Deppermann S, Storchak H, Fallgatter AJ, Ehlis A-C. Stress-induced neuroplasticity: (Mal)adaptation to adverse life events in patients with PTSD – A critical overview. Neuroscience. 2014;283:166-177. doi:https://doi.org/10.1016/j.neuroscience.2014.08.037
4. Alheid GF, Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience. 1988;27(1):1-39. doi:10.1016/0306-4522(88)90217-5
5. Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: Role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2010;35(1):105-135. doi:10.1038/npp.2009.109
6. Minami M. The role of the bed nucleus of the stria terminalis in pain-induced aversive motivation. Curr Opin Behav Sci. 2019;26:46-53. doi:https://doi.org/10.1016/j.cobeha.2018.10.003
7. Hammack SE, Mania I, Rainnie DG. Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol. 2007;98(2):638-656. doi:10.1152/jn.00382.2007
8. Guo J-D, Hammack SE, Hazra R, Levita L, Rainnie DG. Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes. Neuroscience. 2009;164(4):1776-1793. doi:https://doi.org/10.1016/j.neuroscience.2009.09.028
9. Ide S, Hara T, Naka T, et al. Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats. J Neurosci. 2013;33(14):5881-5894. doi:10.1523/jneurosci.4278-12.2013
10. Alexander MJ, Miller MA, Dorsa DM, et al. Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum. Proc Natl Acad Sci. 1989;86(13):5202 LP-5206. doi:10.1073/pnas.86.13.5202
11. St-Gelais F, Jomphe C, Trudeau L-E. The role of neurotensin in central nervous system pathophysiology: what is the evidence? J Psychiatry Neurosci. 2006;31(4):229-245. https://pubmed.ncbi.nlm.nih.gov/16862241.
12. Boules M, Li Z, Smith K, Fredrickson P, Richelson E. Diverse roles of neurotensin agonists in the central nervous system. Front Endocrinol. 2013;4:36. https://www.frontiersin.org/article/10.3389/fendo.2013.00036.
13. Tschumi CW, Sharma R, Lynch WB, Sharpe AL, Beckstead MJ. Depression of substantia nigra dopamine transmission is driven by retrograde neurotensin release and is enhanced by methamphetamine self-administration. bioRxiv. January 2019:717843. doi:10.1101/717843
14. Nimitvilai S, McElvain MA, Arora DS, Brodie MS. Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to Gq. J Neurophysiol. 2012;108(1):263-274. doi:10.1152/jn.01137.2011
15. Normandeau CP, Ventura-silva AP, Hawken ER, et al. A key role for neurotensin in chronic-stress-induced anxiety-like behavior in rats. 2018:285-293. doi:10.1038/npp.2017.134
16. Hara Y, Nakaya H. Dual effects of extracellular ATP on the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells. Eur J Pharmacol. 1997;324(2):295-303. doi:https://doi.org/10.1016/S0014-2999(97)00088-5
17. Hauger R, Risbrough V, Brauns O, Dautzenberg F. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS Neurol Disord - Drug Targets. 2008;5(4):453-479. doi:10.2174/187152706777950684
18. Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: Implications for physiology and pathophysiology. Endocr Rev. 2006;27(3):260-286. doi:10.1210/er.2005-0034
19. Murray AJ. Pharmacological PKA inhibition: All may not be what it seems. Sci Signal. 2008;1(22). doi:10.1126/scisignal.122re4
20. Jüngling K, Liu X, Lesting J, et al. Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor. J Physiol. 2012;590(16):3701- 3717. doi:10.1113/jphysiol.2011.226423
21. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW, Spiess J. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: Role in neuronal excitability and associative learning. J Neurosci. 2003;23(2):700 LP-707. doi:10.1523/JNEUROSCI.23-02-00700.2003
22. Yang LZ, Kocksk̈mper J, Khan S, et al. CAMP- and Ca 2+/calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes. Br J Pharmacol. 2011;162(2):544-556. doi:10.1111/j.1476-5381.2010.01067.x
23. Nagano Y, Kaneda K, Maruyama C, Ide S, Kato F, Minami M. Corticotropin- releasing factor enhances inhibitory synaptic transmission to type III neurons in the bed nucleus of the stria terminalis. Neurosci Lett. 2015;600:56-61. doi:https://doi.org/10.1016/j.neulet.2015.05.059
24. Yamauchi N, Takahashi D, Sugimura YK, Kato F, Amano T, Minami M. Activation of the neural pathway from the dorsolateral bed nucleus of the stria terminalis to the central amygdala induces anxiety-like behaviors. Eur J Neurosci. 2018;48(9):3052-3061. doi:https://doi.org/10.1111/ejn.14165
25. Kudo T, Uchigashima M, Miyazaki T, et al. Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci. 2012;32(50):18035 LP-18046. doi:10.1523/JNEUROSCI.4057- 12.2012
26. Tan KR, Yvon C, Turiault M, et al. GABA neurons of the VTA drive conditioned place aversion. Neuron. 2012;73(6):1173-1183. doi:10.1016/j.neuron.2012.02.015
27. Jennings JH, Sparta DR, Stamatakis AM, et al. Distinct extended amygdala circuits for divergent motivational states. Nature. 2013;496(7444):224-228. doi:10.1038/nature12041
28. Kaneko T, Kaneda K, Ohno A, et al. Activation of adenylate cyclase-cyclic AMP- protein kinase A signaling by corticotropin-releasing factor within the dorsolateral bed nucleus of the stria terminalis is involved in pain-induced aversion. 2016;44:2914-2924. doi:10.1111/ejn.13419
29. Van Pett K, Viau V, Bittencourt JC, et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol. 2000;428(2):191-212. doi:https://doi.org/10.1002/1096-9861(20001211)428:2<191::AID- CNE1>3.0.CO;2-U
30. Takahashi LK. Role of CRF1 and CRF2 receptors in fear and anxiety. Neurosci Biobehav Rev. 2001;25(7):627-636. doi:https://doi.org/10.1016/S0149-7634(01)00046- X
31. Bale TL, Vale WW. CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 2004;44(1):525-557. doi:10.1146/annurev.pharmtox.44.101802.121410
32. Ogawa WN, Baptista V, Aguiar JF, Varanda WA. Neurotensin modulates synaptic transmission in the nucleus of the solitary tract of the rat. Neuroscience. 2005. doi:10.1016/j.neuroscience.2004.09.019
33. Chen L, Yung KKL, Yung WH. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor. Neuroscience. 2004;125(4):853-859. doi:https://doi.org/10.1016/j.neuroscience.2004.02.031
34. Halls ML, Cooper DMF. Regulation by Ca2+-signaling pathways of adenylyl cyclases. Cold Spring Harb Perspect Biol. 2011;3(1):1-22. doi:10.1101/cshperspect.a004143
35. Araujo APN, DeLucia R, Scavone C, Planeta CS. Repeated predictable or unpredictable stress: Effects on cocaine-induced locomotion and cyclic AMP- dependent protein kinase activity. Behav Brain Res. 2003;139(1-2):75-81. doi:10.1016/S0166-4328(02)00088-8
36. Sun H, Wu H, Liu J, Wen J, Zhu Z, Li H. Prenatal stress impairs spatial learning and memory associated with lower mRNA level of the CaMKII and CREB in the adult female rat hippocampus. Neurochem Res. 2017;42(5):1496-1503. doi:10.1007/s11064-017-2206-z